Cita APA (7a ed.)
Berg, J., Bullock, A. J., Whooley, P. D., Peters, M. L. B., Horick, N. K., Zerillo, J. A., . . . Bockorny, B. (2026 Supplsmsnr 2). A phase 2 study of botensilimab and AGEN1423, an anti-CD73-TGFβ-trap bifunctional antibody, in subjects with advanced pancreatic cancer. Journal of Clinical Oncology, 44, 702-847.
Cita Chicago Style (17a ed.)
Berg, Julia, et al. "A Phase 2 Study of Botensilimab and AGEN1423, an Anti-CD73-TGFβ-trap Bifunctional Antibody, in Subjects with Advanced Pancreatic Cancer." Journal of Clinical Oncology 44 (2026 Supplsmsnr 2): 702-847.
Cita MLA (9a ed.)
Berg, Julia, et al. "A Phase 2 Study of Botensilimab and AGEN1423, an Anti-CD73-TGFβ-trap Bifunctional Antibody, in Subjects with Advanced Pancreatic Cancer." Journal of Clinical Oncology, vol. 44, 2026 Supplsmsnr 2, pp. 702-847.
Precaución: Estas citas no son 100% exactas.